174 related articles for article (PubMed ID: 3952477)
1. [Hemoglobin A1c in patients under periodic hemodialysis or continuous ambulatory peritoneal dialysis].
Blumberg A; Marti HR
Schweiz Med Wochenschr; 1986 Feb; 116(7):208-11. PubMed ID: 3952477
[TBL] [Abstract][Full Text] [Related]
2. Serum advanced glycosylation end-products in patients on hemodialysis and CAPD.
Ateshkadi A; Johnson CA; Founds HW; Zimmerman SW
Perit Dial Int; 1995; 15(2):129-33. PubMed ID: 7612732
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated hemoglobin measured by affinity chromatography in diabetic and nondiabetic patients on long-term dialysis therapy.
Tzamaloukas AH; Hsi KC; Quintana BJ; Merlin TL; Avasthi PS
West J Med; 1989 Apr; 150(4):415-9. PubMed ID: 2735046
[TBL] [Abstract][Full Text] [Related]
4. Establishing HbA1c -mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysis.
Zhao C; Luo Q; He F; Peng F; Xia X; Huang F; Yu X
Diabet Med; 2014 Jul; 31(7):813-20. PubMed ID: 24628621
[TBL] [Abstract][Full Text] [Related]
5. [Significance of hemoglobin A1C in the management of diabetes in dialysis patients].
Mácsai E; Rakk E; Miléder M; Fulcz A
Orv Hetil; 2014 Sep; 155(36):1421-5. PubMed ID: 25176516
[TBL] [Abstract][Full Text] [Related]
6. Fructosamine levels in CAPD: its value as glycemic index.
Coronel F; Macia M; Cidoncha A; Sanchez A; Tornero F; Barrientos A; Valor R
Adv Perit Dial; 1991; 7():253-6. PubMed ID: 1680438
[TBL] [Abstract][Full Text] [Related]
7. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test].
Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D
Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236
[TBL] [Abstract][Full Text] [Related]
8. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
[TBL] [Abstract][Full Text] [Related]
9. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus.
Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG
Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin A1c in hemodialysis patients: should one size fit all?
Ix JH
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
[No Abstract] [Full Text] [Related]
11. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
Madden MA; Zimmerman SW; Simpson DP
Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
[TBL] [Abstract][Full Text] [Related]
12. Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis.
Wu MS; Yu CC; Wu CH; Haung JY; Leu ML; Huang CC
Perit Dial Int; 1999; 19 Suppl 2():S179-83. PubMed ID: 10406515
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin A1c in patients on peritoneal dialysis: how should we interpret it?
Coelho S; Rodrigues A
Ther Apher Dial; 2014 Oct; 18(5):375-82. PubMed ID: 24571450
[TBL] [Abstract][Full Text] [Related]
14. Specific affinity-chromatographic measurement of glycated hemoglobins in uremic patients.
Bruns DE; Lobo PI; Savory J; Wills MR
Clin Chem; 1984 Apr; 30(4):569-71. PubMed ID: 6705201
[TBL] [Abstract][Full Text] [Related]
15. Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis.
Tzamaloukas AH; Avasthi PS
Am J Nephrol; 1987; 7(2):101-9. PubMed ID: 3605230
[TBL] [Abstract][Full Text] [Related]
16. Effects of Hemodialysis and Peritoneal Dialysis on Glycometabolism in Patients with End-Stage Diabetic Nephropathy.
Chen XX; Duan Y; Zhou Y
Blood Purif; 2021; 50(4-5):506-512. PubMed ID: 33302273
[TBL] [Abstract][Full Text] [Related]
17. Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
Hoshino J; Larkina M; Karaboyas A; Bieber BA; Ubara Y; Takaichi K; Akizawa T; Akiba T; Fukuhara S; Pisoni RL; Saito A; Robinson BM
Kidney Int; 2017 Aug; 92(2):497-503. PubMed ID: 28396123
[TBL] [Abstract][Full Text] [Related]
18. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
Oei E; Samad N; Visser A; Chowdhury TA; Fan SL
Diabet Med; 2016 Sep; 33(9):e17-20. PubMed ID: 26470840
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia in diabetics on dialysis with poor glycemic control: hemodialysis versus continuous ambulatory peritoneal dialysis.
Tzamaloukas AH; Murata GH; Eisenberg B; Murphy G; Avasthi PS
Int J Artif Organs; 1992 Jul; 15(7):390-2. PubMed ID: 1516987
[TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
Gallieni M; De Salvo C; Lunati ME; Rossi A; D'Addio F; Pastore I; Sabiu G; Miglio R; Zuccotti GV; Fiorina P
Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
